Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern

被引：0
作者：
Marco Falcone
Giusy Tiseo
Beatrice Valoriani
Chiara Barbieri
Sara Occhineri
Paola Mazzetti
Maria Linda Vatteroni
Lorenzo Roberto Suardi
Niccolò Riccardi
Mauro Pistello
Danilo Tacconi
Francesco Menichetti
机构：
[1] Azienza Ospedaliera Universitaria Pisana,Infectious Diseases Unit, Department of Clinical and Experimental Medicine
[2] University of Pisa,Infectious Disease Unit
[3] San Donato Hospital Arezzo,Virology Unit
[4] Pisa University Hospital,Retrovirus Center, Department of Translational Research
[5] University of Pisa,undefined
来源：
Infectious Diseases and Therapy | 2021年 / 10卷
关键词：
Bamlanivimab/etesevimab; Casirivimab/imdevimab; COVID-19; Monoclonal antibodies; SARS-CoV-2; Variants of concern;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2479 / 2488
页数：9
相关论文
共 50 条
  • [21] Discrepancies in Outcomes by Race and Ethnicity in COVID-19 Patients Receiving Casirivimab and Imdevimab
    Zitek, Tony
    Bui, Joseph
    Eily, Alyssa
    Farcy, David A.
    SOUTHERN MEDICAL JOURNAL, 2023, 116 (01) : 15 - 19
  • [22] Clinical Prognosis of Patients With Mild COVID-19 Treated With Casirivimab/Imdevimab in Japan
    Osugi, Yasuhiro
    Iwata, Hitoshi
    Imai, Yasushi
    Kobayashi, Daiki
    Hirashima, Ryutaro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [23] Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia
    Cozzi-Lepri, Alessandro
    Borghi, Vanni
    Rotundo, Salvatore
    Mariani, Bianca
    Ferrari, Anna
    Del Borgo, Cosmo
    Bai, Francesca
    Colletti, Pietro
    Miraglia, Piermauro
    Torti, Carlo
    Cattelan, Anna Maria
    Cenderello, Giovanni
    Berruti, Marco
    Tascini, Carlo
    Parruti, Giustino
    Coladonato, Simona
    Gori, Andrea
    Marchetti, Giulia
    Lichtner, Miriam
    Coppola, Luigi
    Sorace, Chiara
    D'Abramo, Alessandra
    Mazzotta, Valentina
    Guaraldi, Giovanni
    Franceschini, Erica
    Meschiari, Marianna
    Sarmati, Loredana
    Antinori, Andrea
    Nicastri, Emanuele
    Mussini, Cristina
    FRONTIERS IN MEDICINE, 2024, 11
  • [24] French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
    de Canecaude, Claire
    Montastruc, Francois
    Bergeron, Sandrine
    Sanchez-Pena, Paola
    Grandvuillemin, Aurelie
    THERAPIE, 2023, 78 (05): : 517 - 522
  • [25] The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19
    Yang, Rongrong
    Xiong, Yong
    Ke, Hengning
    Chen, Tielong
    Gao, Shicheng
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (11)
  • [26] Covid-19 vaccines and variants of concern: A review
    Hassine, Ikbel Hadj
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (04)
  • [27] Bamlanivimab plus etesevimab treatment have a better outcome against COVID-19: A meta-analysis
    Xiang, Huai-rong
    He, Bei
    Li, Yun
    Cheng, Xuan
    Zhang, Qi-zhi
    Peng, Wen-xing
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1893 - 1905
  • [28] Covid-19 variants of concern and pregnancy
    Stock, Sarah J.
    Harmer, Clea
    Calvert, Clara
    BMJ MEDICINE, 2022, 1 (01):
  • [29] Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
    Isa, Flonza
    Forleo-Neto, Eduardo
    Meyer, Jonathan
    Zheng, Wenjun
    Rasmussen, Scott
    Armas, Danielle
    Oshita, Masaru
    Brinson, Cynthia
    Folkerth, Steven
    Faria, Lori
    Heirman, Ingeborg
    Sarkar, Neena
    Musser, Bret J.
    Bansal, Shikha
    O'Brien, Meagan P.
    Turner, Kenneth C.
    Ganguly, Samit
    Mahmood, Adnan
    Dupljak, Ajla
    Hooper, Andrea T.
    Hamilton, Jennifer D.
    Kim, Yunji
    Kowal, Bari
    Soo, Yuhwen
    Geba, Gregory P.
    Lipsich, Leah
    Braunstein, Ned
    Yancopoulos, George D.
    Weinreich, David M.
    Herman, Gary A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 585 - 592
  • [30] Reverse Takotsubo Cardiomyopathy After Casirivimab-Imdevimab Therapy in a Patient with COVID-19: A Case Report
    Salehin, Salman
    Abu Jazar, Deaa
    Hasan, Syed Mustajab
    Al-Sudani, Hussein
    Raja, Muhammad W.
    AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
12345